Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stem cell expansion product (placenta-derived) is a proprietary, placenta-derived product developed by Medistem Panama for the expansion of various types of stem cells both *ex vivo* (as a tissue culture reagent) and *in vivo*. The product is prepared by conditioning a growth medium through incubation with placental tissue, capturing secreted trophic factors and extracellular vesicles. It is designed to facilitate the potent amplification of a patient's own stem cells prior to reintroduction, or to be administered directly to stimulate endogenous stem cell niches. Potential therapeutic applications include hematopoiesis stimulation post-chemotherapy, tissue regeneration, and cosmetic or anti-aging treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stem cell expansion product (placenta-derived).